Karnataka FDA flags huge price markups by 254 drug companies

Karnataka FDA has flagged alleged excessive markups involving 254 pharmaceutical companies, citing huge gaps between procurement costs and MRPs, and sought NPPA intervention to regulate prices and protect patients.